Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias

NCT00472849 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Richter's Transformation
Leukemia

Interventions

DRUG: Oxaliplatin
DRUG: Fludarabine
DRUG: Cytarabine
DRUG: Rituximab
DRUG: Pegfilgrastim

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]